^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    ADORA2A overexpression

    i
    Other names: ADORA2A, Adenosine A2a Receptor, Adenosine Receptor A2a, ADORA2, RDC8, Adenosine Receptor Subtype A2a
    Entrez ID:
    135
    6ms
    ADORA2A promotes proliferation and inhibits apoptosis through PI3K/AKT pathway activation in colorectal carcinoma. (PubMed, Sci Rep)
    ADORA2A promotes CRC progression and inhibits apoptosis by the PI3K/AKT signaling pathway. It may contribute to the management and treatment of CRC.
    Journal • IO biomarker
    |
    BCL2 (B-cell CLL/lymphoma 2) • CASP3 (Caspase 3) • CASP9 (Caspase 9) • ADORA2A (Adenosine A2a Receptor) • SETDB1 (SET Domain Bifurcated Histone Lysine Methyltransferase 1)
    |
    ADORA2A overexpression